Pros and cons of GnRHa treatment for early puberty in girls (Q38202811)

30 August 2017

Pros and cons of GnRHa treatment for early puberty in girls (English)

1 reference

30 August 2017

Ruben H Willemsen

1

0 references

David B. Dunger

object named as

David B Dunger

series ordinal

5

0 references

Ken K Ong

series ordinal

4

object named as

Ken K Ong

1 reference

30 August 2017

Daniela Elleri

2

1 reference

PubMed ID

24709660

30 August 2017

Rachel M Williams

series ordinal

3

1 reference

30 August 2017

8 April 2014

1 reference

Nature Reviews Endocrinology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

6

1 reference

30 August 2017

352-363

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2014.40

30 August 2017

0 references

cites work

Evolution, development and timing of puberty

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Variations in pattern of pubertal changes in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Onset of breast development in a longitudinal cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Effects of obesity on human sexual development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Childhood obesity and the timing of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Age at puberty and the emerging obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Two-year results of treatment with depot leuprolide acetate for central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Pubertal development in Danish children: comparison of recent European and US data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Are pubertal changes in girls before age 8 benign?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Early puberty: what is normal and when is treatment indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

21 January 2018

Early puberty in girls

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Consensus statement on the use of gonadotropin-releasing hormone analogs in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Disorders of pubertal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Trends in puberty timing in humans and environmental modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Early puberty in adopted children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Increased risk of precocious puberty in internationally adopted children in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Approach to the patient with hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Mutations of the KISS1 gene in disorders of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

A GPR54-activating mutation in a patient with central precocious puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Central precocious puberty caused by mutations in the imprinted gene MKRN3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Epigenetic control of female puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Deciphering puberty: novel partners, novel mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Reduced 'gonadotrophin response to releasing hormone' after chronic administration to impotent men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Depot leuprolide acetate for treatment of precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Final height in central precocious puberty after long term treatment with a slow release GnRH agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Precocious puberty and statural growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Bone mineral density during treatment of central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

GnRH agonist treatment in girls with precocious puberty does not compromise post-pubertal uterine size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Prospective study of factors influencing the onset of natural menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Polycystic ovaries and associated clinical and biochemical features in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Infancy weight gain predicts childhood body fat and age at menarche in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Precocious puberty in adolescent girls: a biomarker of later psychosocial adjustment problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Factors associated with early menarche: results from the French Health Behaviour in School-aged Children (HBSC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Pubertal timing and its link to behavioral and emotional problems among 'at-risk' African American adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Race and perceived pubertal transition effects on girls' depressive symptoms and delinquent behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Pubertal timing and self-reported delinquency among male adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Does early physical maturity influence breast cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Early age at menarche associated with cardiovascular disease and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Age at menarche and type 2 diabetes risk: the EPIC-InterAct study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Diagnostic Work-Up of 449 Consecutive Girls Who Were Referred to be Evaluated for Precocious Puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The variation in age at menarche: an indicator of historic developmental tempo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Secular trends in growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The Timing of Sexual Maturation in a Group of US White Youths

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Studies of gonadotrophin pulsatility and pelvic ultrasound examinations distinguish between isolated premature thelarche and central precocious puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Familial central precocious puberty suggests autosomal dominant inheritance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The effects of cyproterone acetate on statural growth in children with precocious puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Predicting the adult height of girls with central precocious puberty.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Menarche, menopause, and breast cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.40

Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients

31 March 2020

1 reference

12 December 2020

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

12 December 2020

Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty

1 reference

12 December 2020

Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.

1 reference

12 December 2020

Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy

1 reference

12 December 2020

Psychological assessments before and after treatment of early puberty in adopted children

1 reference

12 December 2020

Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.

1 reference

12 December 2020

Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study

1 reference

12 December 2020

Pubertal development in Swiss girls

1 reference

12 December 2020

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an anti

1 reference

12 December 2020

Long-term GnRH-agonist treatment does not postpone central development of the GnRH pule generator in girls with idiopathic precocious puberty.

1 reference

12 December 2020

Common genetic influences on BMI and age at menarche.

1 reference

12 December 2020

Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy

1 reference

12 December 2020

Idiopathic precocious puberty in girls: long-term effects on adolescent behavior

1 reference

12 December 2020

Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.

1 reference

12 December 2020

Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2014.40

1 reference

30 August 2017

1 reference

PubMed ID

24709660